Inspire Medical Systems Lowers FY2026 Adj EPS Guidance from $1.85-$2.35 to $0.75-$1.25 vs $1.88 Est; Lowers FY2026 Sales Guidance from $950.000M-$1.000B to $825.000M-$875.000M vs $962.777M Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 Adj EPS guidance from $1.85-$2.35 to $0.75-$1.25 vs $1.88 analyst estimate. Lowers FY2026 sales outlook from $950.000 million-$1.000 billion to $825.000 million-$875.000 million vs $962.777 million estimate.